Skip to main content

Table 1 Characteristics of patients with a Prior Approval for Restricted Antimicrobials (PARA) request between January 1 and December 31, 2016. Manila, Philippines. “Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship”

From: Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship

 

Total

n (%)a

Definitive

n (%)

Empiric

n (%)

Prophylactic

n (%)

Group size (N)

185

56

127

2

Age (median years)

75.5

78.4

72.7

75.0

Gender (male)

83 (45%)

30 (54%)

52 (41%)

1 (50%)

Total # comorbidities of interest

268

83

183

2

Average # comorbidities per patient

1.45

1.48

1.44

1.00

 Chronic Obstructive Pulmonary Disorder

25

8

16

1

 Hypertension

102

36

66

0

 Diabetes Mellitus

66

23

43

0

 Malignancy (any, active)

51

9

41

1

 Hemodialysis

25

6

19

0

 None

28

7

20

1

Outcome

 Length of hospital days (median days)

14.0

14.5

14.0

15.0

 Mortality

42 (23%)

10 (18%)

32 (25%)

0 (0%)

 Cases with same recurrent infection within 30 days of discharge

14 (8%)

2 (4%)

12 (9%)

0 (0%)

 Duration of therapy (median days)

6.5

7.0

5.0

11.0

Site of infection for PARA request

 Respiratory

145

30

113

2

 Blood

18

8

10

0

 Gastrointestinal

1

1

0

0

 Genitourinary

39

24

15

0

 Wound/surgical site

2

1

1

0

  1. aPercentage within the column